Skip to search.
 FTSE 100 Up 0.26%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
10.25 Down 0.25(2.38%) 16:35
Add to Portfolio
Prev Close:10.50
Open:10.50
Bid:10.00
Ask:10.50
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:10.25 - 10.75
52wk Range:1.91 - 13.38
Volume:1,321,008
Avg Vol (3m):6,919,330
Market Cap:263.19m
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,972.88
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.23
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, develops gene-based medicines and therapeutic vaccines. Its LentiVector platform technology integrates genes into non-dividing cells in the brain and the eye, as well as accommodates multiple ther... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback